Glob Health ActionGlob Health ActionGHAGlobal Health Action1654-97161654-9880Co-Action Publishing2537732942201302536910.3402/gha.v7.25369Indepth Network Cause-Specific MortalityMalaria mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sitesStreatfieldP. Kim123KhanWasif A.234BhuiyaAbbas356HanifiSyed M.A.356AlamNurul378DibouloEric3910SiéAli3910Maurice3910CompaoréYacouba31112SouraAbdramane B.31112BonfohBassirou31314JaegerFabienne31315NgoranEliezer K.31316UtzingerJuerg31315MelakuYohannes A.31718MulugetaAfework31718WeldearegawiBerhe31718GomezPierre31920JassehMomodou31920HodgsonAbraham32122OduroAbraham32122WelagaPaul32122WilliamsJohn32122AwiniElizabeth3232425BinkaFred N.32325GyapongMargaret32325KantShashi32627MisraPuneet32627SrivastavaRahul32627ChaudharyBharat32829JuvekarSanjay32829WahabAbdul33031WilopoSiswanto33031BauniEvasius33233MochamahGeorge33233NdilaCarolyne33233WilliamsThomas N.3323334HamelMary J.33536LindbladeKim A.33536OdhiamboFrank O.33536SlutskerLaurence33536EzehAlex33738KyobutungiCatherine33738WamukoyaMarylene33738DelaunayValérie33940DialloAldiouma33940DouillotLaetitia33940SokhnaCheikh33940Gómez-OlivéF. Xavier34142KabudulaChodziwadziwa W.34142MeePaul34142HerbstKobus34344MossongJoël3434445ChucNguyen T.K.34647ArthurSamuelina S.3SankohOsman A.34849*TannerMarcel50ByassPeter51Matlab HDSS, BangladeshInternational Centre for Diarrhoeal Disease Research, BangladeshINDEPTH Network, Accra, GhanaBandarban HDSS, BangladeshChakaria HDSS, BangladeshCentre for Equity and Health Systems, International Centre for Diarrhoeal Disease Research, BangladeshAMK HDSS, BangladeshCentre for Population, Urbanisation and Climate Change, International Centre for Diarrhoeal Disease Research, BangladeshNouna HDSS, Burkina FasoNouna Health Research Centre, Nouna, Burkina FasoOuagadougou HDSS, Burkina FasoInstitut Supérieur des Sciences de la Population, Université de Ouagadougou, Burkina FasoTaabo HDSS, Côte d’IvoireCentre Suisse de Recherches Scientifiques en Côte d’Ivoire, Abidjan, Côte d’IvoireSwiss Tropical and Public Health Institute, Basel, SwitzerlandUniversité Félix Houphoët-Boigny, Abidjan, Côte d’IvoireKilite-Awlaelo HDSS, EthiopiaDepartment of Public Health, College of Health Sciences, Mekelle University, Mekelle, EthiopiaFarafenni HDSS, The GambiaMedical Research Council, The Gambia Unit, Fajara, The GambiaNavrongo HDSS, GhanaNavrongo Health Research Centre, Navrongo, GhanaDodowa HDSS, GhanaDodowa Health Research Centre, Dodowa, GhanaSchool of Public Health, University of Ghana, Legon, GhanaBallabgarh HDSS, IndiaAll India Institute of Medical Sciences, New Delhi, IndiaVadu HDSS, IndiaVadu Rural Health Program, KEM Hospital Research Centre, Pune, IndiaPurworejo HDSS, IndonesiaDepartment of Public Health, Universitas Gadjah Mada, Yogyakarta, IndonesiaKilifi HDSS, KenyaKEMRI-Wellcome Trust Research Programme, Kilifi, KenyaDepartment of Medicine, Imperial College, St. Mary’s Hospital, LondonKisumu HDSS, KenyaKEMRI/CDC Research and Public Health Collaboration and KEMRI Center for Global Health Research, Kisumu, KenyaNairobi HDSS, KenyaAfrican Population and Health Research Center, Nairobi, KenyaNiakhar HDSS, SenegalInstitut de Recherche pour le Developpement (IRD), Dakar, SénégalAgincourt HDSS, South AfricaMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaAfrica Centre HDSS, South AfricaAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, KwaZulu-Natal, South AfricaNational Health Laboratory, Surveillance & Epidemiology of Infectious Diseases, Dudelange, LuxembourgFilaBavi HDSS, VietnamHealth System Research, Hanoi Medical University, Hanoi, VietnamSchool of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaHanoi Medical University, Hanoi, VietnamWHO Collaborating Centre for Verbal Autopsy, Umeå Centre for Global Health Research, Umeå University, Umeå, SwedenMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaCorrespondence to: Osman A. Sankoh, INDEPTH Network, PO Box KD213, Kanda, Accra, Ghana, Email: osman.sankoh@indepth-network.org

Responsible Editors: Heiko Becher, University of Hamburg, Germany; Nawi Ng, Umeå University, Sweden.

291020142014710.3402/gha.v7.25369037201406920140692014© 2014 INDEPTH Network2014This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Background

Malaria continues to be a major cause of infectious disease mortality in tropical regions. However, deaths from malaria are most often not individually documented, and as a result overall understanding of malaria epidemiology is inadequate. INDEPTH Network members maintain population surveillance in Health and Demographic Surveillance System sites across Africa and Asia, in which individual deaths are followed up with verbal autopsies.

Objective

To present patterns of malaria mortality determined by verbal autopsy from INDEPTH sites across Africa and Asia, comparing these findings with other relevant information on malaria in the same regions.

Design

From a database covering 111,910 deaths over 12,204,043 person-years in 22 sites, in which verbal autopsy data were handled according to the WHO 2012 standard and processed using the InterVA-4 model, over 6,000 deaths were attributed to malaria. The overall period covered was 1992–2012, but two-thirds of the observations related to 2006–2012. These deaths were analysed by site, time period, age group and sex to investigate epidemiological differences in malaria mortality.

Results

Rates of malaria mortality varied by 1:10,000 across the sites, with generally low rates in Asia (one site recording no malaria deaths over 0.5 million person-years) and some of the highest rates in West Africa (Nouna, Burkina Faso: 2.47 per 1,000 person-years). Childhood malaria mortality rates were strongly correlated with Malaria Atlas Project estimates of Plasmodium falciparum parasite rates for the same locations. Adult malaria mortality rates, while lower than corresponding childhood rates, were strongly correlated with childhood rates at the site level.

Conclusions

The wide variations observed in malaria mortality, which were nevertheless consistent with various other estimates, suggest that population-based registration of deaths using verbal autopsy is a useful approach to understanding the details of malaria epidemiology.

malariaAfricaAsiamortalityINDEPTH Networkverbal autopsyInterVA

A Corrigendum has been published for this paper. Please see http://www.globalhealthaction.net/index.php/gha/article/view/27833

This paper is part of the Special Issue: INDEPTH Network Cause-Specific Mortality. More papers from this issue can be found at http://www.globalhealthaction.net

The epidemiology of malaria in Africa and Asia has been extensively, but not always systematically, investigated. Many studies have focused on young children’s exposure to the disease (1), and to some extent the effects on pregnant women (2), without evaluating the malaria status of other population sub-groups. Few studies have looked specifically at the impact of malaria on older people (3). Many data have been taken from heath facilities at various levels and may be influenced by patterns of health services utilisation rather than clearly representing malaria patterns within communities (4). Some work has taken whatever data may be available and sought to generalise patterns of malaria burden using sophisticated modelling techniques (5). Nevertheless, malaria remains as an important cause of infectious disease mortality in many parts of Africa, and some areas in Asia and Latin America. WHO’s World Malaria Report 2013 suggests that malaria mortality rates fell by more than 40% from 2000 to 2012, a period during which there was substantial international investment in malaria control (6). However, although malaria transmission has successfully been reduced in many former high-incidence settings, few areas have become malaria-free. The need for adequate, reliable evidence on malaria mortality in various populations therefore remains as important as ever, and data at the population level are crucially needed to validate and understand top-down estimates.

As is the case for deaths from all diseases, malaria deaths are generally poorly verified and documented in Africa and some parts of Asia. Attributing a death to malaria after the event is not easy – in highly endemic areas, acute febrile deaths may be likely to be described as malaria and lead to over-attribution, whereas the converse may apply in settings where malaria is uncommon. It has been suggested that over-attribution of malaria as a clinical diagnosis in endemic areas may even be dangerous (7). Because most malaria deaths occur in areas not covered by routine death certification, verbal autopsy (VA) methods have been used in many settings as the only available source of cause of death data, but their validity in absolute terms for assigning malaria as a cause of death remains open to question. Rapid diagnostic tests (RDTs) are becoming increasingly widely used as a basis for malaria treatment decisions, and, where RDT results are known from an illness leading to death, either positive or negative RDT results may increase the available VA information and hence the accuracy of cause of death attribution. Consequently in the WHO 2012 VA standard, specific items on a recent positive or negative test result were introduced (8). However, it will be some time before sufficient VAs are collected which include those data items to assess their utility as part of the VA process.

In this paper, we present malaria-specific mortality rates derived from standardised VA data in 22 INDEPTH Network Health and Demographic Surveillance Sites (HDSS) across Africa and Asia (9). Although these HDSSs are not designed to form a representative network, each one follows a geographically defined population longitudinally, systematically recording all death events and undertaking VAs on deaths that occur. Sites with longer time-series may therefore be able to measure changes over time effectively. Our aim is to present the malaria mortality patterns at each site, comparing these community-level findings with other information on malaria in Africa and Asia.

Methods

The overall public-domain INDEPTH dataset (10) from which these malaria-specific analyses are drawn is described in detail elsewhere (11), with full details of methods used, which are also summarised here in Box 1. Briefly, the dataset documents 111,910 deaths in 12,204,043 person-years of observation across 22 sites, all processed in a standardised manner. The Karonga site in Malawi did not contribute VAs for children, and for that reason is excluded from further analyses here. The InterVA-4 ‘high’ malaria setting was used for all the West African sites, plus the East African sites (with the exceptions, on the grounds of high altitude, of Nairobi, Kenya and Kilite-Awlaelo, Ethiopia), on the basis of local experience. All other sites used the ‘low’ setting; the ‘very low’ setting was not used. The InterVA-4 guideline is that the ‘high’ setting is appropriate for an expected malaria cause-specific mortality fraction (CSMF) higher than about 1%, though the setting chosen does not result in any great dichotomisation of outputs; the clinical equivalent would be a physician’s knowledge that his/her current case comes from a setting where malaria is more or less likely, irrespective of particular symptoms.

Box 1. Summary of methodology based on the detailed description in the introductory paper (11)

Age–sex–time standardisation

To avoid effects of differences and changes in age–sex structures of populations, mortality fractions and rates have been adjusted using the INDEPTH 2013 population standard (12). A weighting factor was calculated for each site, age group, sex and year category in relation to the standard for the corresponding age group and sex, and incorporated into the overall dataset. This is referred to in this paper as age–sex–time standardisation in the contexts where it is used.

Cause of death assignment

The InterVA-4 (version 4.02) probabilistic model was used for all the cause of death assignments in the overall dataset (13). InterVA-4 is fully compliant with the WHO 2012 Verbal Autopsy Standards and generates causes of death categorised by ICD-10 groups (14). The data reported here were collected before the WHO 2012 VA standard was available, but were transformed into the WHO 2012 and InterVA-4 format to optimise cross-site standardisation in cause of death attribution. For a small proportion of deaths VA interviews were not successfully completed; a few others contained inadequate information to arrive at a cause of death. InterVA-4 assigns causes of death (maximum 3) with associated likelihoods; thus cases for which likely causes did not total 100% were also assigned a residual indeterminate component. This served as a means of encapsulating uncertainty in cause of death at the individual level within the overall dataset, as well as accounting for 100% of every death.

Overall dataset

The overall public-domain dataset (10) thus contains between one and four records for each death, with the sum of likelihoods for each individual being unity. Each record includes a specific cause of death, its likelihood and its age-sex-time weighting.

Deaths assigned to malaria were extracted from the overall data set together with data on person-time exposed by site, year, age and sex. Overall malaria mortality as reflected here amounted to a total of 6,330.8 age–sex–time standardised deaths, to which 8,076 individually recorded deaths contributed some component of probable malaria mortality. As each HDSS covers a total population, rather than a sample, uncertainty intervals are not shown.

In this context, all of these data are secondary datasets derived from primary data collected separately by each participating site. In all cases the primary data collection was covered by site-level ethical approvals relating to on-going health and demographic surveillance in those specific locations. No individual identity or household location data were included in the secondary data and no specific ethical approvals were required for these pooled analyses.

Results

The CSMFs for malaria at each site are shown, together with the population-based malaria-specific mortality rate per 1,000 person-years, in Fig. 1. In West African sites, malaria CSMF ranged from 4.90% to 25.53%, with malaria-specific standardised mortality rates ranging from 0.48 to 2.47 per 1,000 person-years. In Eastern and Southern Africa, CSMFs were 0.40–11.61%, with rates from 0.06 to 2.15 per 1,000 person-years. In Asia, CSMFs were 0–4.25%, with rates from 0 to 0.24 per 1,000 person-years. One site, AMK in Bangladesh, recorded no malaria deaths in over 0.5 million person-years of observation.

Map showing participating sites, with age–sex–time standardised cause-specific mortality fractions and mortality rates for malaria.

Table 1 breaks down malaria-specific mortality rates by age group and site. Malaria mortality rates among infants varied considerably, from 0 to 1.4 per 1,000 person-years, with the highest rates not necessarily being in the locations with highest overall malaria mortality. The largest numbers of malaria deaths at most sites occurred in the 1–4 year age group, though the highest malaria mortality rate in that age group was 0.43 per 1,000 person-years at Taabo, Côte d’Ivoire. Malaria mortality rates in the 5–14 year age group were generally lower than the rates for younger children. Similarly, malaria mortality rates among adults were generally lower than those for children, although they tended to increase among the elderly. Figure 2 shows malaria-specific mortality rates for each site by age group, split into time periods (1992–1999; 2000–2005 and 2006–2012), depending on periods when individual sites operated. Logarithmic scales have been used to visualise both high and low levels of malaria mortality while using the same scale for each site. For most sites and most periods there were generally U-shaped relationships between malaria mortality rates and age; naturally more random variation was evident in sites with generally low malaria mortality because of relatively small numbers of cases.

Malaria mortality rates by site, age group and period at 20 INDEPTH Network sites.

Malaria-specific deaths and mortality rates per 1,000 person-years, by age group and site

Age group at death

Country: SiteInfant1–4 years5–14 years15–49 years50–64 years65+ years
Bangladesh: Matlab
 Deaths0.000.410.000.000.000.00
 Rate/1,000 py0.000.000.000.000.000.00
Bangladesh: Bandarban
 Deaths0.981.002.463.761.473.25
 Rate/1,000 py0.790.170.180.110.251.03
Bangladesh: Chakaria
 Deaths0.431.231.990.000.000.28
 Rate/1,000 py0.080.060.030.000.000.03
Bangladesh: AMK
 Deaths0.000.000.000.000.000.00
 Rate/1,000 py0.000.000.000.000.000.00
Burkina Faso: Nouna
 Deaths507.76859.38140.73108.9376.24287.96
 Rate/1,000 py0.750.200.110.070.420.70
Burkina Faso: Ouagadougou
 Deaths19.4868.0317.908.562.724.43
 Rate/1,000 py0.720.190.100.040.240.90
Côte d’Ivoire: Taabo
 Deaths22.7463.228.2422.792.998.56
 Rate/1,000 py1.420.430.140.110.431.35
Ethiopia: Kilite-Awlaelo
 Deaths1.832.221.221.000.704.93
 Rate/1,000 py0.570.130.030.020.060.41
The Gambia: Farafenni
 Deaths35.28113.1138.7243.3519.8543.46
 Rate/1,000 py1.060.330.150.090.551.15
Ghana: Navrongo
 Deaths121.42283.4239.5012.349.4532.61
 Rate/1,000 py0.420.100.040.020.060.14
Ghana: Dodowa
 Deaths4.7449.5328.83154.6745.91138.68
 Rate/1,000 py0.280.140.060.030.210.26
India: Ballabgarh
 Deaths5.4117.893.644.250.005.38
 Rate/1,000 py0.450.200.040.020.000.26
India: Vadu
 Deaths0.000.000.000.910.000.00
 Rate/1,000 py0.000.000.000.010.000.00
Indonesia: Purworejo
 Deaths2.423.132.004.345.6413.50
 Rate/1,000 py0.850.190.050.020.140.19
Kenya: Kilifi
 Deaths38.5390.2136.0314.843.9712.72
 Rate/1,000 py0.170.040.020.010.050.18
Kenya: Kisumu
 Deaths672.201177.46177.79321.3099.16181.89
 Rate/1,000 py0.380.100.040.030.140.17
Kenya: Nairobi
 Deaths16.4216.504.597.233.910.26
 Rate/1,000 py0.800.180.040.020.150.05
Senegal: Niakhar
 Deaths23.25126.4521.3216.314.0428.49
 Rate/1,000 py1.050.330.150.090.220.68
South Africa: Africa Centre
 Deaths8.6713.847.379.441.537.22
 Rate/1,000 py0.330.120.030.020.030.17
South Africa: Agincourt
 Deaths12.4529.3919.4554.407.564.93
 Rate/1,000 py0.280.140.050.030.080.08
Vietnam: FilaBavi
 Deaths0.000.000.000.550.002.46
 Rate/1,000 py0.000.000.000.010.000.14

We undertook a sensitivity analysis to examine the effects of the ‘high’ and ‘low’ InterVA-4 malaria settings across this large and diverse dataset. Re-running the InterVA-4 model with the ‘high’ and ‘low’ settings reversed at site level gave the results shown in Fig. 3. Incorrect use of the ‘high’ setting in low malaria populations appeared to result in high relative rates of falsely attributed malaria, although the numbers involved would still be relatively small at the lowest endemicities. Conversely using the ‘low’ setting in high malaria populations reduced the number of malaria assignments. Although the rate ratios changed less in high endemicity settings, the numbers of cases involved would be important with increasing rates.

Sensitivity analysis showing the effect of choosing the ‘wrong’ malaria endemicity setting (‘high’ and ‘low’ reversed) in processing VA data using the InterVA-4 model, by site.

Table 2 shows estimates of malaria-specific mortality rates for the countries with INDEPTH sites reporting here, for the under-5 and 5-plus age groups for comparison with other sources of malaria mortality estimates. INDEPTH estimates for countries with multiple sites were derived as population-weighted average rates.

Within-country estimates of malaria-specific mortality rates derived from WHO/CHERG (42, 43), IHME (44) compared with population-weighted average country rates from INDEPTH sites

WHO/CHERGIHMEINDEPTH

CountryUnder 5 years5 years and overUnder 5 years5 years and overUnder 5 years5 years and over
Bangladesh0.050.0040.050.020.020.006
Burkina Faso9.940.158.341.196.081.00
Côte d’Ivoire6.920.135.490.925.040.57
Ethiopia0.38?1.860.360.320.06
Ghana2.900.112.990.582.400.30
India0.060.020.040.040.530.03
Indonesia0.110.030.800.040.740.08
Kenya0.47?1.860.443.350.31
Senegal2.390.051.960.592.950.39
The Gambia4.310.145.550.462.340.61
Vietnam0.0040.0000.0030.01300.015

The Malaria Atlas Project (MAP) produced geo-referenced estimates of Plasmodium falciparum parasite rates (PfPR) across endemic areas for children aged 2–10 years in 2010 (15). Since all the INDEPTH HDSSs cover defined small areas, it was possible to extract a PfPR value for each endemic site from the MAP data. Where sites covered more than one cell of the MAP surface, all the cells relating to the site were averaged. Data were available for 14 sites with childhood malaria mortality data; data were not available for seven sites in Vietnam, India, Bangladesh and Ethiopia, presumably because of very low or uncertain endemicity. Figure 4 shows the correlation between per-site malaria mortality rates for the 1–14 year age group as determined by InterVA-4 and the MAP PfPR values for the same geographic locations. The line in Fig. 4 represents a highly significant correlation (R 2=0.69, p=0.002), fitting the relationship:Malaria mortality rate=e[(PfPR×0.6274)+0.7023]

Scatter plot of age–sex–time standardised InterVA malaria mortality rates per 1,000 person-years for children aged 1–14 years versus Plasmodium falciparum parasite rate data for children aged 2–10 years, for 14 INDEPTH HDSS sites reporting malaria mortality which also had geo-referenced parasite rate data for 2010 in the Malaria Atlas Project (15). Line shows correlation, R 2=0.56. (1. Africa Centre, South Africa; 2. Agincourt, South Africa; 3. Nairobi, Kenya; 4. Purworejo, Indonesia; 5. Bandarban, Bangladesh; 6. Kilifi, Kenya; 7. Dodowa, Ghana; 8. Navrongo, Ghana; 9. Farafenni, The Gambia; 10. Ouagadougou, Burkina Faso; 11. Niakhar, Senegal; 12. Taabo, Côte d’Ivoire; 13. Kisumu, Kenya; 14. Nouna, Burkina Faso).

An important area of uncertainty in malaria epidemiology is the ratio of malaria-specific mortality rates between children and adults. Seventeen sites recorded malaria deaths in both under-15 and over-15 year age categories. Apart from one outlier (Dodowa, Ghana, where the malaria-specific mortality rate ratio for over-15: under-15 age categories was 2.5), in the remaining 16 sites the malaria-specific mortality rate ratios for over-15:under-15 age categories were in the range 0.05 to 0.82, while overall malaria-specific mortality rates ranged from 0.018 to 2.47 per 1,000 person-years. Figure 5 shows the correlation between adult and child malaria rates for these 17 sites, shown on logarithmic scales for clarity. As expected, the sites from West Africa dominate the top-right quadrant, together with Kisumu, on the shores of Lake Victoria in Kenya. Other African and Asian sites largely occupy the lower-left quadrant, with the Chakaria site in Bangladesh showing very low malaria mortality rates for both adults and children. The per-site correlation (represented by the line in Fig. 5) between age–sex–time standardised adult and child malaria mortality rates was highly significant (R 2=0.65, p=0.0001), fitting the relationship: Adult malaria mortality rate=e[(child malaria mortality rate×1.002)-1.157]

Scatter plot of age–sex–time standardised malaria mortality rates per 1,000 person-years for adults (15 years and over) and children (under 15 years), for 17 INDEPTH HDSS sites reporting malaria mortality among adults and children. Line shows correlation, R 2=0.65.

Discussion

These results represent widely-based evidence on malaria mortality, which has not previously been documented at the population level on this scale, using standardised methods. The interpretation of findings at individual sites depends on local characteristics (1636). Two sites, Ouagadougou in Burkina Faso and Nairobi in Kenya, followed urban populations and recorded lower levels of malaria than some of their rural neighbours. Bandarban in Bangladesh is located in a frontier zone close to the Myanmar border, which may explain higher rates of malaria compared with other sites in Bangladesh; this is consistent with WHO malaria mapping for Bangladesh (37). The very low overall levels of malaria mortality in Bangladesh are not only consistent with expectations, but form an important part of these analyses in that they suggest our methods are capable of assigning malaria as a cause of death with high specificity. Kisumu in Kenya is located on the shores of Lake Victoria, in an area known to have higher malaria transmission than most other parts of the country, such as the coastal area around Kilifi (38). Kilite-Awlaelo is located in the Ethiopian highlands, at an altitude around 2,000 m above sea level, at which malaria is typically unstable and epidemic in nature. The two South African sites are located on the margins of malaria transmission, and some of the relatively few cases that occurred may reflect travel, for example to neighbouring Mozambique (39).

The validity of VA cause of death assignment specifically for malaria is difficult to determine precisely. The InterVA model has previously been used in a WHO study of malaria treatment, showing a significant difference in malaria-specific mortality following a treatment delivery intervention (40). A review of VA methodological validations in relation to hospital data found some examples relating to malaria, but a generalisable formal validation for malaria mortality remains elusive (41). In principle validity of VA methods for malaria as a cause of death could be established in a large VA dataset from an endemic area which included systematic parasitaemia testing across all age groups. Operationally this could be incorporated in a minimally-invasive autopsy approach (42). The Population Health Metrics Research Consortium (PHMRC) collected a ‘gold standard’ VA dataset of 12,530 tertiary facility cases, which contained 216 cases meeting the PHMRC definitions of a malaria death (basically diagnoses based on parasitaemia and fever) (43, 44). Unfortunately however there were no data on the presence or absence of malaria parasitaemia in cases attributed to other causes, nor on parasite species for the malaria cases. Most (64%) of the adult malaria deaths in this series came from hospitals in India, while the childhood cases were mainly from Dar-es-Salaam city (88%), though it should be noted that this study did not aim to represent any particular population. Only 25% of the malaria deaths mentioned the word ‘malaria’ in the open-ended part of the subsequent VA interview (which did not contain any specific question on malaria), while 69% of malaria case VAs for adults and 54% for children reported severe respiratory symptoms. This may partly reflect the tertiary facility settings of these cases, where some cases may have progressed to respiratory complications of malaria (45), or VA respondents may simply have noted hospital treatment for breathing difficulties in the trajectory towards death (46). Consequently, the PHMRC dataset is not particularly useful in terms of validating VA in general for malaria.

The WHO 2012 VA standard (8) includes indicators relating to positive or negative malaria test results during the final illness, as well as other relevant symptomatic parameters. However, because these data were collected before the WHO 2012 standard was directly implemented for data capture, specific responses for these indicators were missing in over 90% of cases. However, a previous sensitivity analysis showed that InterVA-4 was generally relatively robust in relation to missing data items (46). Nevertheless, the malaria-specific outputs here, using the WHO 2012 standard and the corresponding InterVA-4 model, show huge differences between locations and age groups, as might be expected. These plausible patterns suggest that there may be at least a reasonable degree of validity in terms of InterVA-4’s assignment of malaria deaths. The application of a standard probabilistic model such as InterVA-4 at least guarantees that inter-site differences are reflections of variations in the VA source data (13). If, alternatively, physicians at each site were used to assign cause of death, it would be easy for inter- and intra-physician variations to contribute to apparent differences between sites and over time. This is the first time such a large VA dataset relating to malaria has been compiled that spans complete populations in Africa and Asia, covers a wide spectrum of endemicity, and uses standardised cause of death attribution. The sensitivity analysis reported here is important in justifying the design assumptions in InterVA-4 that require local settings for malaria (and HIV) endemicity. The crossover region between the ‘high’ and ‘low’ settings, recommended at 1%, has been seen as a difficult concept by some InterVA-4 users. However, the sensitivity analysis shown in Fig. 3 suggests that this setting is both important and appropriate, and analogous to a clinician’s local knowledge of malaria endemicity, irrespective of the history and symptomatology of the next patient.

There are other major pieces of work describing malaria mortality in Africa and Asia, using totally different methods, with which these findings can be compared and contrasted. The WHO World Malaria Report 2013 (6) sets out WHO’s most recent compilation of malaria reports from its member countries, together with associated data estimates in the WHO Global Health Observatory (47) and, for children, from the Child Epidemiology Reference Group (CHERG) (48). The Institute of Health Metrics and Evaluation (IHME) has also published global and country estimates of malaria mortality covering a similar time period, based on mathematical modelling of available data (49). Both of these sources take the approach of gathering whatever malaria mortality data may be available across all endemic areas (to which this dataset now adds), and then making best estimates to fill in the considerable gaps in the available data.

Table 2 enables comparisons of malaria-specific mortality rates for the countries with INDEPTH sites reporting here, for the under-5 and 5-plus age groups, with other sources of estimates. South Africa is not included because the majority of the country is malaria-free, while the two INDEPTH sites represent marginal transmission areas, making national estimates difficult to interpret. WHO and CHERG publish separate data estimates for all-age malaria deaths and under-5 malaria deaths, respectively; while these are largely congruent, allowing the calculation of 5-plus deaths, for Kenya and Ethiopia the number of under-5 deaths exceeded total deaths, so that no rate could be calculated for the 5-plus age group. Comparisons between these three data sources have to be interpreted with care. The WHO/CHERG and IHME numbers come from estimates based on such data as are available, modelled to represent the national situation as far as is possible, and may include facility and community sources, as well as diverse methods of cause of death assignment. The INDEPTH numbers come from the specific HDSS populations as described above, which are not intended to be nationally representative, but which are collected and processed in a standardised way across the various countries represented. In the case of Kenya, for example, the higher INDEPTH rate for under-5s reflects high malaria mortality in the Kisumu area. While it would be inappropriate to over-interpret comparisons of the rates presented in Table 2, it is clear that there are substantial similarities between all three sources. IHME and INDEPTH figures tend towards higher rates for the 5-plus age group, though the reasons for this are not clear. In INDEPTH’s case, InterVA-4 appears to be detecting a number of acute febrile illnesses among older people and attributing them as malaria; but there is absolutely no associated biomedical evidence that these deaths are indeed directly due to malaria.

However, Fig. 4 showed a strong correlation between InterVA-4 estimates of childhood malaria mortality and geo-referenced parasite prevalence estimates from MAP (15). There are three possible consequences to consider. Firstly, if one accepts the validity of the parasite prevalence estimates, then the observed correlation suggests that for children (notwithstanding the slightly different age groups of 1–14 years for mortality and 2–10 years for parasite prevalence), InterVA-4 is capturing a directly related pattern of malaria mortality, across a 100-fold range of endemicity. The second option is to accept the validity of the InterVA-4 malaria mortality findings reported here, in which case they add veracity to the parasite prevalence estimates. Thirdly, if both the InterVA-4 and MAP findings are considered to be reasonably valid, then this correlation establishes an interesting relationship between childhood parasite prevalence and malaria mortality. This relationship seems to hold over a wide range of sites, even though it might be reasonable to presume that local factors such as the effectiveness of treatment and control programmes could also play a part. Previous work (among hospitalised cases) in Tanzania showed relationships between age, transmission intensity and malaria mortality (50). Another modelling study sought to establish relationships between malaria transmission and mortality, though starting from a rather disparate group of datasets (51).

Figure 5 showed a strong correlation between InterVA-4 adult and childhood malaria mortality rates at the site level. If InterVA-4 were generally misclassifying a wide range of acute adult febrile illnesses as malaria, this would not be the expected pattern. If there were appreciable misclassification, the so-called ‘malaria’ deaths in adults might be expected to occur at a rate largely independent of childhood malaria mortality, in the absence of any hypothesis as to other causes of acute adult febrile mortality that happened to correlate geographically with childhood malaria. However, there were clearly much higher rates of what InterVA-4 was calling ‘malaria’ among adults in West Africa, where malaria transmission is known to be the highest in the world. A more detailed analysis of malaria mortality by age from the Kisumu site in Kenya showed complex and changing relationships between malaria mortality and age (52). Because malaria surveillance among older people has generally not been given high priority, there appears to be a need for further population-based research to further resolve this question.

The public availability of these malaria mortality data creates interesting opportunities for further analyses. Apart from contributing to the overall body of malaria mortality data, there are several other ways in which they may be specifically useful. While one can debate the generalisability of HDSS sites (53), the cross-site relationships established here between gridded parasite prevalence data and childhood malaria mortality, and between child and adult malaria mortality rates, could well be incorporated into wider estimations of malaria mortality.

Conclusions

Measuring malaria mortality effectively continues to be a global problem. As remarked in the context of malaria transmission modelling (54), malaria mortality events frequently fall under the radar of health information systems. The data presented here, from a wide range of INDEPTH HDSSs across Africa and Asia, demonstrate the value of detailed longitudinal surveillance in defined populations, rather than relying on more disparate sources. VA may not be an ideal tool for tracking malaria, but nevertheless the malaria-specific mortality rate estimates obtained here using the WHO 2012 standard and the InterVA-4 model closely correspond to other sources of estimates, despite the 1:10,000 range in the magnitude of rates measured using the same methods in different settings. More widespread use of these population-based approaches would add considerably to global understanding of malaria, and thereby inform control and elimination programmes.

Acknowledgements

We are grateful to all the residents of INDEPTH HDSS sites who have contributed personal information to this mortality dataset, and to the field staff who undertook so many verbal autopsy interviews and data management staff who handled the data at every participating site. INDEPTH acknowledges all the site scientists who have participated in bringing this work together, and who participated in analysis workshops in Ghana, Belgium, Thailand and the United Kingdom. The INDEPTH Network is grateful for core funding from Sida, the Wellcome Trust, and the William & Flora Hewlett Foundation. The Umeå Centre for Global Health Research is core funded by Forte, the Swedish Research Council for Health, Working Life and Welfare (grant 2006-1512). PB’s residency at the University of the Witwatersrand Rural Knowledge Hub to analyse and draft these results was supported by the European Community Marie Curie Actions IPHTRE project (no. 295168). icddr,b is thankful to the Governments of Australia, Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. The Ouagadougou site acknowledges the Wellcome Trust for its financial support to the Ouagadougou HDSS (grant number WT081993MA). The Kilite Awlaelo HDSS is supported by the US Centers for Disease Control and Prevention (CDC) and the Ethiopian Public Health Association (EPHA), in accordance with the EPHA-CDC Cooperative Agreement No.5U22/PS022179_10 and Mekelle University, though these findings do not necessarily represent the funders’ official views. The Farafenni HDSS is supported by the UK Medical Research Council. The Kilifi HDSS is supported through core support to the KEMRI-Wellcome Trust Major Overseas Programme from the Wellcome Trust. TNW is supported by a Senior Fellowship (091758) and CN through a Strategic Award (084538) from the Wellcome Trust. This paper is published with permission from the Director of KEMRI. The Kisumu site wishes to acknowledge the contribution of the late Dr. Kubaje Adazu to the development of KEMRI/CDC HDSS, which was implemented and continues to be supported through a cooperative agreement between KEMRI and CDC. The Nairobi Urban Health and Demographic Surveillance System (NUHDSS), Kenya, since its inception has received support from the Rockefeller Foundation (USA), the Welcome Trust (UK), the William and Flora Hewlett Foundation (USA), Comic Relief (UK), the Swedish International Development Cooperation Agency (SIDA) and the Bill and Melinda Gates Foundation (USA). The Agincourt site acknowledges that the School of Public Health and Faculty of Health Sciences, University of the Witwatersrand, and the Medical Research Council, South Africa, have provided vital support since inception of the Agincourt HDSS. Core funding has been provided by the Wellcome Trust, UK (Grants 058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z) with contributions from the National Institute on Aging of the NIH, William and Flora Hewlett Foundation, and Andrew W Mellon Foundation, USA.

Authors are listed arbitrarily in order of their site code, and alphabetically within each site.

Conflict of interest and funding

The authors have not received any funding or benefits from industry or elsewhere to conduct this study.

ReferencesFinkGOlgiatiAHawelaMMillerJMMatafwaliBAssociation between early childhood exposure to malaria and children’s pre-school development: evidence from the Zambia early childhood development projectMalar J2013121223297692AmegahAKDampteyOKSarpongGADuahEVervoornDJJaakkolaJJKMalaria infection, poor nutrition and indoor air pollution mediate socioeconomic differences in adverse pregnancy outcome in Cape Coast, GhanaPLoS ONE20138e6918123894428SankohOAKynast-WolfGKouyateBBecherHPatterns of adult and old-age mortality in rural Burkina FasoJ Public Health Med200325372614747599OkiroEAKazembeLNKabariaCWLigomekaJNoorAMAliDChildhood malaria admission rates to four hospitals in Malawi between 2000 and 2010PLoS ONE20138e6221423638008GriffinJTFergusonNMGhaniACEstimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan AfricaNat Commun20145313624518518World Health OrganizationWorld Malaria Report 20132013GenevaWorld Health OrganizationAvailable from: http://www.who.int/iris/bitstream/10665/97008/1/9789241564694_eng.pdf [cited 25 February 2014]ReyburnHMbatiaRDrakeleyCCarneiroIMwakasungulaEMwerindeOOverdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective studyBMJ2004329121215542534LeitaoJChandramohanDByassPJakobRBundhamcharoenKChoprapawonCRevising the WHO verbal autopsy instrument to facilitate routine cause-of-death monitoringGlob Health Action2013621518, http://dx.doi.org/10.3402/gha.v6i0.21518SankohOByassPThe INDEPTH Network: filling vital gaps in global epidemiologyInt J Epidemiol2012415798822798690INDEPTH NetworkINDEPTH Network Cause-Specific Mortality – Release 2014Provided by the INDEPTH Network Data Repository201410www.indepth-network.org10.7796/INDEPTH.GH003.COD2014.v1StreatfieldPKKhanWABhuiyaAAlamNSieASouraABCause-specific mortality in Africa and Asia: evidence from INDEPTH Health and Demographic Surveillance System sitesGlob Health Action2014725362, http://dx.doi.org/10.3402/gha.v7.25362SankohOSharrowDHerbstKKabudulaCWAlamNKantSThe INDEPTH standard population for low- and middle-income countries, 2013Glob Health Action2014723286, http://dx.doi.org/10.3402/gha.v7.23286ByassPChandramohanDClarkSJD’AmbruosoLFottrellEGrahamWJStrengthening standardised interpretation of verbal autopsy data: the new InterVA-4 toolGlob Health Action2012519281, http://dx.doi.org/10.3402/gha.v5i0.19281World Health OrganizationVerbal Autopsy Standards: the 2012 WHO Verbal Autopsy Instrument2012GenevaWHOAvailable from: http://www.who.int/healthinfo/statistics/WHO_VA_2012_RC1_Instrument.pdf [cited 25 February 2014]GethingPWPatilAPSmithDLGuerraCAElyazarIRJohnstonGLA new world malaria map: Plasmodium falciparum endemicity in 2010Malar J20111037822185615RazzaqueANaharLAkter KhanamMStreatfieldPKSocio-demographic differentials of adult health indicators in Matlab, Bangladesh: self-rated health, health state, quality of life and disability levelGlob Health Action201034618, http://dx.doi.org/10.3402/gha.v3i0.4618INDEPTH NetworkBandarban HDSSAvailable from: http://www.indepth-network.org/Profiles/Bandarban HDSS.pdfHanifiMAMamunAAPaulAHasanSAHoqueSSharminSProfile: the Chakaria Health and Demographic Surveillance SystemInt J Epidemiol2012416677522798692LindeboomWDasSCAshrafAHealth and Demographic Surveillance Report 2009 – Abhoynagar and Mirsarai2011Dhaka, BangladeshICDDR,BSiéALouisVRGbangouAMüllerONiambaLStieglbauerGThe Health and Demographic Surveillance System (HDSS) in Nouna, Burkina Faso, 1993–2007Glob Health Action201035284, http://dx.doi.org/10.3402/gha.v3i0.5284RossierCSouraABayaBCompaoréGDabiréBDos SantosSProfile: the Ouagadougou Health and Demographic Surveillance SystemInt J Epidemiol2012416586622685112KouadioMKRighettiAAAbéNNWegmüllerRWeissMGN’goranEKLocal concepts of anemia-related illnesses and public health implications in the Taabo health demographic surveillance system, Côte d’IvoireBMC Hematol201313524499516WeldearegawiBAshebirYGebeyeEGebregziabiherTYohannesMMussaSEmerging chronic non-communicable diseases in rural communities of Northern Ethiopia: evidence using population-based verbal autopsy method in Kilite Awlaelo surveillance siteHealth Policy Plan201328891823293101OduroARWakGAzongoDDebpuurCWontuoPKondayireFProfile: the Navrongo Health and Demographic Surveillance SystemInt J Epidemiol2012419687622933645GyapongMSarpongDAwiniEManyehAKTeiDOdonkorGProfile: the Dodowa Health and Demographic Surveillance SystemInt J Epidemiol20134216869624415607JassehMWebbELJaffarSHowieSTownendJSmithPGReaching Millennium Development Goal 4 – the GambiaTrop Med Int Health20111613142521707875NgNHakimiMSantosaAByassPWilopoSAWallSIs self-rated health an independent index for mortality among older people in Indonesia?PLoS One20127e3530822523584KantSMisraPGuptaSGoswamiKKrishnanANongkynrihBProfile: the Ballabgarh Health and Demographic Surveillance System (CRHSP-AIIMS)Int J Epidemiol20134237644HirveSJuvekarSSambhudasSLelePBlomstedtYWallSDoes self-rated health predict death in adults aged 50 years and above in India? Evidence from a rural population under health and demographic surveillanceInt J Epidemiol20124117192723175517ScottJABauniEMoisiJCOjalJGatakaaHNyundoCProfile: The Kilifi Health and Demographic Surveillance System (KHDSS)Int J Epidemiol201241650722544844OdhiamboFOLasersonKFSeweMHamelMJFeikinDRAdazuKProfile: the KEMRI/CDC Health and Demographic Surveillance System – Western KenyaInt J Epidemiol2012419778722933646OtiSOMutuaMMgomellaGSEgondiTEzehAKyobutungiCHIV mortality in urban slums of Nairobi, Kenya 2003–2010: a period effect analysisBMC Public Health20131358823773503DelaunayVDouillotLDialloADioneDTrapeJFMedianikovOProfile: the Niakhar Health and Demographic Surveillance SystemInt J Epidemiol20134210021124062286KahnKCollinsonMAGómez-OlivéFXMokoenaOTwineRMeePProfile: Agincourt health and socio-demographic surveillance systemInt J Epidemiol201241988100122933647HerbstAJMafojaneTNewellMLVerbal autopsy-based cause-specific mortality trends in rural KwaZulu-Natal, South Africa, 2000–2009Popul Health Metr201194721819602HuongDLMinhHVVosTJanlertUVanDDByassPBurden of premature mortality in rural Vietnam from 1999–2003: analyses from a Demographic Surveillance SitePopul Health Metr20064916893472World Health Organization. Malaria country profiles: Bangladesh2013GenevaWHOAvailable from: http://www.who.int/malaria/publications/country-profiles/profile_bgd_en.pdf [cited 25 February 2014]World Health Organization. Malaria country profiles: Kenya2013GenevaWHOAvailable from: http://www.who.int/malaria/publications/country-profiles/profile_ken_en.pdf [cited 25 February 2014]World Health Organization. Malaria country profiles: South Africa2013GenevaWHOAvailable from: http://www.who.int/malaria/publications/country-profiles/profile_zaf_en.pdf [cited 25 February 2014].LemmaHByassPDestaABosmanAConstanzoGTomaLDeploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resourcesTrop Med Int Health2010152415019961564LeitaoJDesaiNAleksandrowiczLByassPMiasnikofPTollmanSComparison of physician-certified verbal autopsy with computer-coded verbal autopsy for cause of death assignment in hospitalized patients in low-and middle-income countries: systematic reviewBMC Med2014122224495312MudendaVLucasSShibembaAO’GradyJBatesMKapataNTuberculosis and tuberculosis/HIV/AIDS-associated mortality in Africa: the urgent need to expand and invest in routine and research autopsiesJ Infect Dis2012205Suppl 2S340622448024MurrayCJLopezADBlackRAhujaRAliSMBaquiAPopulation Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasetsPopul Health Metr201192721816095Population Health Metrics Research ConsortiumPHMRC Gold Standard Verbal Autopsy Data 2005–2011Available from: http://ghdx.healthmetricsandevaluation.org/search/site/phmrc [cited 25 February 2014]ByassPCampbellHO’DempseyTJGreenwoodBMCoincidence of malaria parasitaemia and abnormal chest X-ray findings in young Gambian childrenJ Trop Med Hyg1991942231995930ByassPUsefulness of the Population Health Metrics Research Consortium gold standard verbal autopsy data for general verbal autopsy methodsBMC Medicine2014122324495341World Health OrganizationGlobal Health Observatory: Number of malaria deathsAvailable from: www.who.int/gho/malaria/epidemic/deaths/en/ [cited 25 February 2014]Child Epidemiology Reference GroupEstimated numbers of deaths by cause in children younger than 5 years by WHO region and country2010Available from: http://cherg.org/publications/Country-level-child-deaths-2000-2010.xls [cited 25 February 2014]MurrayCJLRosenfeldLCLimSSAndrewsKGForemanKJHaringDGlobal malaria mortality between 1980 and 2010: a systematic analysisLancet20123794133122305225ReyburnHMbatiaRDrakeleyCBruceJCarnieroIOlomiRAssociation of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malariaJAMA200529314617015784869RossAMaireNMolineauxLSmithTAn epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum Am J Trop Med Hyg200675Suppl 2637316931817DesaiMBuffAMKhagayiSByassPAmekNvan EijkAAge-specific malaria mortality rates in the KEMRI/CDC Health and Demographic Surveillance System in Western Kenya, 2003–2010PLoS ONE20149e10619725180495ByassPSankohOTollmanSMHögbergUWallSLessons from history for designing and validating epidemiological surveillance in uncounted populationsPLoS ONE20116e2289721826215NoorAMKinyokiDKMundiaCWKabariaCWMutuaJWAleganaVAThe changing risk of Plasmodium falciparum malaria infection in Africa: 2000–2010: a spatial and temporal analysis of transmission intensityLancet201438317394724559537